12月19日，创新药概念震荡反弹，益方生物涨近10%，新诺威、维康药业、亚虹医药、阳光诺和、悦康药业跟涨。消息面上，新版国家医保目录里新增了111种5年内新上市药品，50种为1类新药，无论是比例还是数量，都创历年新高。此外，今年以来，北京、上海、重庆、四川等多地出台相关政策，促进医药健康产业创新，推动创新药行业高质量发展。另据多家媒体报道，12月18日凌晨（北京时间），参议院官网显示，搭载修订版《...
Source Link12月19日，创新药概念震荡反弹，益方生物涨近10%，新诺威、维康药业、亚虹医药、阳光诺和、悦康药业跟涨。消息面上，新版国家医保目录里新增了111种5年内新上市药品，50种为1类新药，无论是比例还是数量，都创历年新高。此外，今年以来，北京、上海、重庆、四川等多地出台相关政策，促进医药健康产业创新，推动创新药行业高质量发展。另据多家媒体报道，12月18日凌晨（北京时间），参议院官网显示，搭载修订版《...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.